Nasus Pharma Ltd funding
Nasus Pharma Ltd, a biotechnology company based in Tel Aviv, Israel, filed a Form D with the SEC on February 25, 2026 and reported $15M raised.
Amount raised$15M
Offering size$15M
Filed with the SECFebruary 25, 2026
First saleFebruary 10, 2026
IndustryBiotechnology
SecuritiesEquity, Options or warrants, Security to be acquired on exercise
LocationTel Aviv, Israel
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far15
Minimum investment—
Revenue rangeNo Revenues
View the original Form D on SEC EDGAR ↗ · All rounds filed Feb 25
Other health care rounds
Lisata Therapeutics, Inc.$352M · Oct 2BiotechnologyPrecision Neuroscience Corp$250M · Sep 28Other Health CareZai Lab Ltd$250M · Nov 9BiotechnologyAmerican Republic Insurance Co.$95M · Oct 22Health InsuranceBridge To Life Ltd.$82.5M · Oct 21Other Health CareAlpfa Medical, Inc.$80.3M · Sep 28Other Health CareBigHat Biosciences, Inc.$75.1M · Oct 26BiotechnologyTypewriter Therapeutics, Inc.$56.3M · Sep 21Biotechnology